IN THE NEWS

Respiratory

24September2026

Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply

– Ritedose expands albuterol inhalation solution production and strengthens its role as a trusted source for inhaled solutions. – The Company ramped up multiple albuterol inhalation solution strengths during national shortage, reinforcing its role as a trusted source for inhaled…

Albuterol inhalation solution supply and manufacturing at Ritedose

10September2026

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

The role will focus on identifying new opportunities and strengthening existing customer relationships to accelerate Ritedose’s continued growth.

Carolyn Berg, Vice President of Strategic Growth at Ritedose

2September2026

One Size No Longer Fits All in Pharmaceutical Manufacturing

Specialized CDMOs combine precision, agility and scale to meet the evolving needs of complex pharmaceutical manufacturing. This is production on purpose.

Specialized CDMO pharmaceutical manufacturing at Ritedose

22May2026

Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing

Ritedose explores how purpose-driven pharmaceutical manufacturing strengthens quality, innovation and patient-centered care.

Ritedose pharmaceutical manufacturing team focused on purpose-driven innovation

10April2026

What Does it Mean to be a Manufacturer of Choice?

Ritedose explains how quality, reliability, and Blow-Fill-Seal (BFS) expertise define what it means to be a true manufacturer of choice in pharmaceutical manufacturing.

Manufacturer of Choice pharmaceutical manufacturing at Ritedose

27March2026

Meeting Patient Needs Through Flexible Pharmaceutical Manufacturing

Pharmaceutical manufacturing at scale requires flexibility, cGMP compliance and advanced technology to ensure safe, reliable medications for patients.

Pharmaceutical Manufacturing facility producing sterile medications using Blow-Fill-Seal technology

27February2026

How Ritedose Addresses Drug Shortages

Ritedose helps address drug shortages by using advanced sterile manufacturing and strategic partnerships to keep essential treatments available.

Ritedose sterile pharmaceutical manufacturing addressing drug shortages.

30January2026

Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US

This overview explores Ritedose, the largest U.S. pharmaceutical CDMO, and how its aseptic Blow-Fill-Seal technology supports large-scale branded and generic drug manufacturing.

Ritedose Blow-Fill-Seal Technology | Aerial view of Ritedose pharmaceutical manufacturing facilities in Columbia, South Carolina, showcasing the largest U.S. Blow-Fill-Seal CDMO.

16January2026

How Ritedose Supports a Stable and Reliable Medication Supply

Learn how Ritedose safeguards patients’ access to critical medications with responsive, high-quality pharmaceutical manufacturing.

Automated pharmaceutical warehouse with a yellow robotic arm stacking cardboard boxes, illustrating Ritedose’s focus on transparency, efficiency, and solutions for drug shortages.

29October2025

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

The Ritedose Corporation (Ritedose) announced that the U.S. Food and Drug Administration (FDA) approved its manufacturing and distribution of Tobramycin Inhalation Solution to treat patients six years and older with infections of Pseudomonas aeruginosa, a common bacterial infection among cystic…

16September2025

How Blow-Fill-Seal Technology Ensures Sterile Medication Delivery

Discover how Ritedose leads the industry in delivering safe, scalable, and contamination-free drug products through advanced BFS innovation.

16September2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

September 17, 2024 — The Ritedose Corporation, Inc. (Ritedose), the largest CDMO in the United States specializing in sterile Blow Fill Seal (BFS) production of unit dose solutions for the ophthalmic and respiratory markets, is proud to partner with Verona…

FEATURED NEWS

16th September 2026

Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing

ESCP Business School students visiting Ritedose Manufacturing Center of Excellence at University of South Carolina partnership event

RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

Respiratory

Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

One Size No Longer Fits All in Pharmaceutical Manufacturing

Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing

What Does it Mean to be a Manufacturer of Choice?

Meeting Patient Needs Through Flexible Pharmaceutical Manufacturing

How Ritedose Addresses Drug Shortages

Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US

How Ritedose Supports a Stable and Reliable Medication Supply

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

How Blow-Fill-Seal Technology Ensures Sterile Medication Delivery

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

FEATURED NEWS

How a Culture of Learning Improves Pharmaceutical Manufacturing Quality

One Size No Longer Fits All in Pharmaceutical Manufacturing

Resilience Is a Commitment to Learning

Patient Behavior Drives a Better Design

Hidden Contamination: What Preservative-Free Ophthalmic Patients Need to Know

Why Reclosing a Single-Use Ophthalmic Vial Doesn’t Restore Sterility

Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing

Eyedrop recall underscores need for quality focus

Why Pharmaceutical Resilience Is Critical in Drug Manufacturing

Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing

RECEIVE THE LATEST NEWS

TAGS CLOUD

Quick Links

Receive the latest news.

Respiratory

FEATURED NEWS

RECEIVE THE LATEST NEWS

TAGS CLOUD

Tags

Quick Links

Receive the latest news.